Incannex Healthcare Statistics
Total Valuation
IXHL has a market cap or net worth of $42.59 million. The enterprise value is -$31.74 million.
| Market Cap | 42.59M |
| Enterprise Value | -31.74M |
Important Dates
The last earnings date was Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IXHL has 11.96 million shares outstanding. The number of shares has increased by 1,452.12% in one year.
| Current Share Class | 11.96M |
| Shares Outstanding | 11.96M |
| Shares Change (YoY) | +1,452.12% |
| Shares Change (QoQ) | +6.01% |
| Owned by Insiders (%) | 12.08% |
| Owned by Institutions (%) | 7.28% |
| Float | 9.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 4.58 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 41.56, with a Debt / Equity ratio of 0.00.
| Current Ratio | 41.56 |
| Quick Ratio | 41.47 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -117.17% and return on invested capital (ROIC) is -36.78%.
| Return on Equity (ROE) | -117.17% |
| Return on Assets (ROA) | -32.19% |
| Return on Invested Capital (ROIC) | -36.78% |
| Return on Capital Employed (ROCE) | -31.71% |
| Weighted Average Cost of Capital (WACC) | 19.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.03M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.96% in the last 52 weeks. The beta is 2.84, so IXHL's price volatility has been higher than the market average.
| Beta (5Y) | 2.84 |
| 52-Week Price Change | -45.96% |
| 50-Day Moving Average | 3.78 |
| 200-Day Moving Average | 8.59 |
| Relative Strength Index (RSI) | 47.85 |
| Average Volume (20 Days) | 297,654 |
Short Selling Information
The latest short interest is 834,495, so 6.97% of the outstanding shares have been sold short.
| Short Interest | 834,495 |
| Short Previous Month | 801,478 |
| Short % of Shares Out | 6.97% |
| Short % of Float | 8.45% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.84M |
| Pretax Income | -48.41M |
| Net Income | -48.41M |
| EBITDA | -24.70M |
| EBIT | -24.84M |
| Earnings Per Share (EPS) | -$5.22 |
Balance Sheet
The company has $74.45 million in cash and $114,000 in debt, with a net cash position of $74.34 million or $6.21 per share.
| Cash & Cash Equivalents | 74.45M |
| Total Debt | 114,000 |
| Net Cash | 74.34M |
| Net Cash Per Share | $6.21 |
| Equity (Book Value) | 75.23M |
| Book Value Per Share | 5.50 |
| Working Capital | 78.17M |
Cash Flow
In the last 12 months, operating cash flow was -$17.72 million and capital expenditures -$11,000, giving a free cash flow of -$17.73 million.
| Operating Cash Flow | -17.72M |
| Capital Expenditures | -11,000 |
| Depreciation & Amortization | 148,000 |
| Net Borrowing | -1.52M |
| Free Cash Flow | -17.73M |
| FCF Per Share | -$1.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IXHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,452.12% |
| Shareholder Yield | -1,452.12% |
| Earnings Yield | -113.66% |
| FCF Yield | -41.64% |
Analyst Forecast
The average price target for IXHL is $17.86, which is 401.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.86 |
| Price Target Difference | 401.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 27, 2026. It was a reverse split with a ratio of 1:30.
| Last Split Date | Feb 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
IXHL has an Altman Z-Score of 5.81 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.81 |
| Piotroski F-Score | 2 |